Featured Research

from universities, journals, and other organizations

Heart attack risk doubles after COPD exacerbation, study finds

Date:
May 7, 2010
Source:
American College of Chest Physicians
Summary:
Patients with chronic obstructive pulmonary disease (COPD) who experience an exacerbation have an increased risk for both myocardial infarctions (MI) and ischemic stroke, according to a new study.

Patients with chronic obstructive pulmonary disease (COPD) who experience an exacerbation have an increased risk for both myocardial infarctions (MI) and ischemic stroke.

Researchers from the United Kingdom analyzed the risk of MI or stroke after exacerbation of COPD in 25,857 patients with the disease. Among the patients, 524 MI were identified in 426 patients and 633 ischemic strokes in 482 patients.

Results showed that exacerbation rates were significantly higher in patients with COPD experiencing MI or stroke compared with those who did not suffer from these conditions. In addition, there was a 2.27-fold increased risk of MI 1 to 5 days after a COPD exacerbation and a 1.26-fold increase of stroke 1 to 49 days after a COPD exacerbation.

Researchers suggest the findings provide good rationale for treating patients with COPD in both the stable and exacerbation states to reduce cardiovascular events.

This study is published in the May issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians.


Story Source:

The above story is based on materials provided by American College of Chest Physicians. Note: Materials may be edited for content and length.


Journal Reference:

  1. G. C. Donaldson, J. R. Hurst, C. J. Smith, R. B. Hubbard, J. A. Wedzicha. Increased risk of Myocardial Infarction and Stroke following Exacerbation of Chronic Obstructive Pulmonary Disease.. Chest, 2009; DOI: 10.1378/chest.09-2029

Cite This Page:

American College of Chest Physicians. "Heart attack risk doubles after COPD exacerbation, study finds." ScienceDaily. ScienceDaily, 7 May 2010. <www.sciencedaily.com/releases/2010/05/100504082735.htm>.
American College of Chest Physicians. (2010, May 7). Heart attack risk doubles after COPD exacerbation, study finds. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2010/05/100504082735.htm
American College of Chest Physicians. "Heart attack risk doubles after COPD exacerbation, study finds." ScienceDaily. www.sciencedaily.com/releases/2010/05/100504082735.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins